Plain-English translation of NCT06939751 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking for patterns in patients' blood after a heart transplant that can help doctors know if their anti-rejection medications are at the right level. Right now, doctors have to guess a bit — too much medication can cause dangerous infections, and too little can cause the body to reject the new heart. Researchers hope to create a simple blood test that takes the guesswork out of this balance.
After a heart transplant, patients must take medications to prevent their immune system from attacking the new heart. However, these medications also weaken the immune system, making infections more likely. This study exists to find a better way to monitor these medications so doctors can protect both the transplant and the patient's health.
You likely qualify if…
You likely don't qualify if…
You would come to your transplant center for regular follow-up visits (which you would already be having after your transplant). At these visits and whenever you have health concerns like possible rejection or infection, the doctors will collect blood samples for the research. Over three years, you'll also share information about your medications, health history, and any complications you experience. The study uses your routine care and standard tests — no extra procedures beyond what's already part of transplant follow-up.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States